IRIS UniCatt

Hohaus, Stefan
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.796
EU - Europa 7.214
AS - Asia 6.665
SA - Sud America 1.170
AF - Africa 183
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 10
Totale 24.070
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.535
SG - Singapore 2.903
DE - Germania 2.295
CN - Cina 1.689
SE - Svezia 1.111
BR - Brasile 965
VN - Vietnam 813
IT - Italia 752
PL - Polonia 719
FR - Francia 568
UA - Ucraina 456
GB - Regno Unito 348
IN - India 280
FI - Finlandia 262
IE - Irlanda 250
ID - Indonesia 175
JP - Giappone 169
RU - Federazione Russa 129
CA - Canada 128
HK - Hong Kong 118
TR - Turchia 90
BD - Bangladesh 88
MX - Messico 83
AR - Argentina 63
IQ - Iraq 56
NL - Olanda 54
ZA - Sudafrica 46
PK - Pakistan 43
AT - Austria 41
ES - Italia 36
BE - Belgio 35
CI - Costa d'Avorio 32
CO - Colombia 31
VE - Venezuela 30
EC - Ecuador 29
AU - Australia 28
KR - Corea 27
CZ - Repubblica Ceca 26
MA - Marocco 26
IR - Iran 24
LT - Lituania 22
UZ - Uzbekistan 21
AE - Emirati Arabi Uniti 20
SA - Arabia Saudita 20
KE - Kenya 19
CH - Svizzera 18
PY - Paraguay 18
IL - Israele 16
MY - Malesia 14
GR - Grecia 13
EG - Egitto 12
PE - Perù 12
PH - Filippine 12
RO - Romania 12
TN - Tunisia 12
AZ - Azerbaigian 11
JO - Giordania 11
CL - Cile 10
NP - Nepal 10
CR - Costa Rica 9
DZ - Algeria 8
ET - Etiopia 8
HN - Honduras 8
KZ - Kazakistan 8
LV - Lettonia 8
BG - Bulgaria 7
JM - Giamaica 7
UY - Uruguay 7
AL - Albania 6
DK - Danimarca 6
NO - Norvegia 6
PT - Portogallo 6
XK - ???statistics.table.value.countryCode.XK??? 6
DO - Repubblica Dominicana 5
GE - Georgia 5
HU - Ungheria 5
OM - Oman 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BO - Bolivia 4
BY - Bielorussia 4
CG - Congo 4
EU - Europa 4
HR - Croazia 4
LY - Libia 4
NI - Nicaragua 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
CU - Cuba 3
KW - Kuwait 3
LB - Libano 3
SN - Senegal 3
TW - Taiwan 3
BB - Barbados 2
BH - Bahrain 2
CY - Cipro 2
GH - Ghana 2
GT - Guatemala 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 24.030
Salva come PNG Salva come JPEG
Città #
Singapore 1.621
Chandler 1.039
Ashburn 881
San Jose 855
Warsaw 691
Jacksonville 338
Beijing 295
Munich 257
Dublin 241
Ho Chi Minh City 234
Los Angeles 230
Nanjing 223
San Mateo 223
Hanoi 213
Houston 205
Ann Arbor 201
Fairfield 200
New York 195
Woodbridge 195
Dearborn 193
Wilmington 184
Lauterbourg 177
Jakarta 155
Rome 149
Milan 144
Tokyo 143
Hefei 134
Helsinki 128
Cambridge 127
The Dalles 127
Nürnberg 122
Seattle 112
Frankfurt am Main 109
Chicago 107
Hong Kong 106
Dallas 102
Cattolica 98
Boston 88
Bremen 88
Nanchang 85
Moscow 84
Redmond 77
São Paulo 75
Lawrence 72
Buffalo 71
Santa Clara 69
Redwood City 68
Marseille 58
Princeton 58
Hyderabad 57
St Louis 55
Kunming 54
Council Bluffs 53
London 52
Lancaster 46
Shanghai 46
Orem 45
Da Nang 43
Haiphong 42
Guangzhou 40
Izmir 40
Montreal 40
Kent 38
Tianjin 38
Norwalk 35
Hangzhou 34
Nuremberg 34
Abidjan 32
Brussels 31
Hebei 31
Toronto 31
Brooklyn 30
Mexico City 30
Mountain View 29
Shenyang 29
Zhengzhou 29
Boardman 28
Jiaxing 28
Rio de Janeiro 27
Changsha 26
Seoul 26
Johannesburg 25
Auburn Hills 24
Belo Horizonte 24
Fremont 24
Leawood 23
Amsterdam 22
Atlanta 22
Baghdad 22
Paris 22
Stockholm 22
Chennai 21
Phoenix 21
Turku 21
University Park 21
Denver 20
Poplar 20
Düsseldorf 19
Nairobi 19
Lappeenranta 18
Totale 13.256
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 432
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 363
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 340
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 328
Fanconi anemia gene variants in therapy-related myeloid neoplasms 322
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients 290
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 287
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 285
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 280
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 240
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 233
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 231
Italian real-life experience with brentuximab vedotin: Results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma 231
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 230
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 227
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 221
Why methylation is not a marker predictive of response to hypomethylating agents 198
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 192
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 192
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 192
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 191
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 190
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 188
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 188
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 188
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 184
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 182
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 181
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 180
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 180
Epigenetic changes in therapy-related MDS/AML 179
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 179
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 176
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 175
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 174
Clonal evolution in therapy-related neoplasms 173
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 172
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 171
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 170
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 170
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 169
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 169
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 169
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 164
Primary multifocal lymphoma of peripheral nervous system: Case report and review of the literature 160
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 159
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 158
Cardiovascular involvement in patients affected by multiple myeloma: a comprehensive review of recent advances 158
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 157
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 157
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 156
Iron in Hodgkin's lymphoma 155
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 155
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 155
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 155
Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma. 154
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine. 154
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 153
PU.1 and CEBPA expression in acute myeloid leukemia. 153
Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET). 153
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) 153
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 152
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 152
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 152
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 151
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 151
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 151
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 150
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 150
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 149
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 149
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 149
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 148
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 147
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 146
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 144
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 144
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 143
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 143
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden 141
Small lymphocytic lymphoma in a patient with Fabry disease 139
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 139
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 138
Outcome of therapy-related myeloid neoplasms treated with azacitidine 137
Mantle cell lymphoma relapsing at the lymphedematous arm 137
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 137
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 136
Prognostic factors in hodgkin lymphoma 136
Dural MALT Lymphoma Detected by 11C-Methionine PET/CT 136
Small lymphocytic lymphoma in a patient with Fabry disease 134
Clinical and prognostic features of lymphomas arising in the head and neck region: Our experience of preferential association of different histotypes with various sites of origin in ninety patients 134
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 134
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 134
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 133
Desensitization to thalidomide in a patient with multiple myeloma 132
Muscle Recurrence of a Primarily Nodal Follicular Lymphoma Studied by Contrast-Enhanced 18F-FDG PET/CT 132
Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy 132
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 127
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma 126
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 125
Totale 17.711
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.676
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021338 0 0 0 0 0 0 0 0 0 0 287 51
2021/20221.293 151 111 20 53 85 36 38 206 64 102 208 219
2022/20232.865 385 396 203 502 180 353 140 230 303 49 84 40
2023/20241.300 56 383 42 66 39 204 52 87 11 39 150 171
2024/20253.391 98 114 247 159 298 119 229 167 456 289 675 540
2025/20268.593 1.167 281 517 857 1.600 547 1.638 562 653 727 44 0
Totale 24.391